Seer, Inc. (SEER)

Market Cap	124.17M
Revenue (ttm)	15.31M
Net Income (ttm)	-85.87M
Shares Out	58.85M
EPS (ttm)	-1.41
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,154
Open	2.180
Previous Close	2.190
Day's Range	2.110 - 2.180
52-Week Range	1.585 - 2.625
Beta	1.58
Analysts	Hold
Price Target	3.00 (+42.18%)
Earnings Date	Aug 7, 2025

About SEER

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratori...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Dec 4, 2020
• Employees: 134
• Stock Exchange: NASDAQ
• Ticker Symbol: SEER
• Website: https://seer.bio

Financial Performance

In 2024, Seer, Inc.'s revenue was $14.17 million, a decrease of -14.95% compared to the previous year's $16.66 million. Losses were -$86.60 million, 0.37% more than in 2023.

Analyst Summary

According to one analyst, the rating for SEER stock is "Hold" and the 12-month stock price target is $3.0.

Price Target

$3.0

(42.18% upside)

Analyst Consensus: Hold